Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

NCT00859222 is registered in ClinicalTrials.gov with Patrick Y. Wen, MD as lead sponsor.

NCT NCT00859222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00859222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
Lead sponsor
Patrick Y. Wen, MD
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2009
Completion date
December 31, 2015
Enrollment
51 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malignant glioma